Nonimpact of Decolonization as an Adjunctive Measure to Contact Precautions for the Control of Methicillin-Resistant Staphylococcus aureus Transmission in Acute Care
- 1 January 2016
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (1) , 99-104
Abstract
This was an observational study comparing methicillin-resistant Staphylococcus aureus (MRSA) transmission with no decolonization of medical patients to required decolonization of all MRSA carriers during two consecutive periods: baseline with no decolonization of medical patients (16 months) and universal MRSA carrier decolonization (13 months). The setting was a one-hospital, 156-bed facility with 9,200 annual admissions. Regression models were used to compare rates of MRSA acquisition. The chi-square test was used to compare event frequencies. We used rates of MRSA clinical disease as an outcome monitor of the program. Analysis was done on 15,666 patients who had admission and discharge tests; 27.9% of inpatient days were occupied by a MRSA-positive patient (colonized patient-days) who received decolonization while hospitalized during the baseline period (this 27.9% represented those who had planned surgery) compared to 76.0% during the intervention period ( P < 0.0001). The rate of MRSA transmission was 97 events (1.0%) for 9,415 admissions (2.0 transmission events/1,000 patient-days) during baseline and was 87 (1.4%) for 6,251 admissions (2.7 transmission events/1,000 patient-days) during intervention ( P = 0.06; rate ratio, 0.74; 95% confidence interval [CI], 0.55 to 1.00). The MRSA nosocomial clinical disease rate was 5.9 infections/10,000 patient-days in the baseline period and was 7.2 infections/10,000 patient-days for the intervention period (rate ratio, 0.82; 95% CI, 0.46 to 1.45; P = 0.49). Decolonization of MRSA patients does not add benefit when contact precautions are used for patients colonized with MRSA in acute (hospital) care.Keywords
Funding Information
- HHS Agency for Healthcare Research and Quality (1R18HSO19968-01)
- Roche
This publication has 31 references indexed in Scilit:
- Clinical Significance of Methicillin-Resistant Staphylococcus aureus Colonization on Hospital Admission: One-Year Infection RiskPLOS ONE, 2013
- The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance SystemClinical Microbiology and Infection, 2013
- Reduced Costs for Staphylococcus aureus Carriers Treated Prophylactically with Mupirocin and Chlorhexidine in Cardiothoracic and Orthopaedic SurgeryPLOS ONE, 2012
- Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 yearsJournal of Antimicrobial Chemotherapy, 2012
- Methicillin-Resistant Staphylococcus aureus Colonization and Risk of Subsequent Infection in Critically Ill Children: Importance of Preventing Nosocomial Methicillin-Resistant Staphylococcus aureus TransmissionClinical Infectious Diseases, 2011
- The Human Nasal Microbiota and Staphylococcus aureus CarriagePLOS ONE, 2010
- Point-Counterpoint: To Screen or Not To Screen for Methicillin-Resistant StaphylococcusaureusJournal of Clinical Microbiology, 2010
- Preventing Surgical-Site Infections in Nasal Carriers ofStaphylococcus aureusNew England Journal of Medicine, 2010
- Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics eraJournal of Clinical Investigation, 2009
- Staphylococcus aureus Nasal Decolonization in Joint Replacement Surgery Reduces InfectionClinical Orthopaedics and Related Research, 2008